Skip to main content
Log in

Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke

  • Case Report
  • Published:
Emergency Radiology Aims and scope Submit manuscript

Abstract

Methotrexate (MTX) is an indispensable antimetabolite for the treatment of oncological and immunological disorders in all age groups. It can be administrated intravenously as well as intrathecally and may be used alone or in combination with other drugs. Chronic leukoencephalopathy is a well-known side effect of MTX, especially in conjunction with intrathecal administration. However, acute neurotoxicity with confusion, disorientation, seizures, and focal deficits may also be seen. This can clinically mimic stroke with restricted diffusion on MRI. However, unlike stroke, there is resolution of clinical and imaging findings within 1–4 weeks. We report two cases of transient leukoencephalopathy following intrathecal methotrexate, with complete clinical and radiological resolutions on follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Inaba H, Khan RB, Laningham FH et al (2008) Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178–184

    Article  PubMed  CAS  Google Scholar 

  2. Baehring JM, Fulbright RK (2008) Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 79:535–539

    Article  PubMed  CAS  Google Scholar 

  3. Fisher MJ, Khademian ZP, Simon EM et al (2005) Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. Am J Neuroradiol 26:1686–1689

    PubMed  Google Scholar 

  4. Shuper A, Stark B, Kornreich L (2002) Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. Isr Med Assoc J 4:1050–1053

    PubMed  CAS  Google Scholar 

  5. Sandoval C, Kutscher M, Jayabose S et al (2003) Neurotoxicity of intrathecal methotrexate: MR imaging findings. Am J Neuroradiol 24:1887–1890

    PubMed  Google Scholar 

  6. Quinn CT, Griener JC, Bottiglieri T et al (1997) Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 15:2800–2806

    PubMed  CAS  Google Scholar 

  7. McKinney AM, Kieffer SA, Paylor RT et al (2009) Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. Am J Roentgenol 193:192–206

    Article  Google Scholar 

  8. Kuker W, Bader P, Herrlinger U et al (2005) Transient encephalopathy after intrathecal methotrexate chemotherapy: diffusion-weighted MRI. J Neuro Oncol 73:47–49

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amit Agarwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agarwal, A., Vijay, K., Thamburaj, K. et al. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke. Emerg Radiol 18, 345–347 (2011). https://doi.org/10.1007/s10140-010-0931-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10140-010-0931-6

Keywords

Navigation